Literature DB >> 23178848

Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.

Yinong Zong1, Rongsheng Jin.   

Abstract

The neuromuscular junction (NMJ) is the most extensively studied model of neuronal synaptogenesis. Acetylcholine receptor (AChR) clustering on the postsynaptic membrane is a cardinal event in the differentiation of NMJs. AChR clustering and postsynaptic differentiation is orchestrated by sophisticated interactions among three proteins: the neuron-secreted proteoglycan agrin, the co-receptor LRP4, and the muscle-specific receptor tyrosine kinase MuSK. LRP4 and MuSK act as scaffolds for multiple binding partners, resulting in a complex and dynamic network of interacting proteins that is required for AChR clustering. In this review, we discuss the structural basis for NMJ postsynaptic differentiation mediated by the agrin-LRP4-MuSK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178848      PMCID: PMC4627850          DOI: 10.1007/s00018-012-1209-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  106 in total

1.  Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.

Authors:  X Yang; S Arber; C William; L Li; Y Tanabe; T M Jessell; C Birchmeier; S J Burden
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

2.  Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv.

Authors:  M H Xie; J Yuan; C Adams; A Gurney
Journal:  Nat Biotechnol       Date:  1997-08       Impact factor: 54.908

Review 3.  The roles of Dok family adapters in immunoreceptor signaling.

Authors:  Ryuichi Mashima; Yukihiro Hishida; Tohru Tezuka; Yuji Yamanashi
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

4.  Calcium plays a critical role in determining the acetylcholine receptor-clustering activities of alternatively spliced isoforms of Agrin.

Authors:  Chao-Neng Tseng; Lili Zhang; Michael Cascio; Zuo-Zhong Wang
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

Review 5.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

7.  The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.

Authors:  Z Songyang; B Margolis; M Chaudhuri; S E Shoelson; L C Cantley
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

8.  Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse.

Authors:  Dominique Simon-Chazottes; Sylvie Tutois; Michael Kuehn; Martin Evans; Franck Bourgade; Sue Cook; Muriel T Davisson; Jean-Louis Guénet
Journal:  Genomics       Date:  2006-03-06       Impact factor: 5.736

9.  Alternative RNA splicing that determines agrin activity regulates binding to heparin and alpha-dystroglycan.

Authors:  J T Campanelli; G G Gayer; R H Scheller
Journal:  Development       Date:  1996-05       Impact factor: 6.868

10.  Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations.

Authors:  H Zhou; D J Glass; G D Yancopoulos; J R Sanes
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  27 in total

1.  Non-synaptic roles of acetylcholinesterase and agrin.

Authors:  Katarina Gros; Giulia Parato; Sergej Pirkmajer; Katarina Mis; Matej Podbregar; Zoran Grubic; Paola Lorenzon; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2013-12-11       Impact factor: 3.444

2.  [Sepsis impairs aggregation of nicotinic acetylcholine receptors on murine skeletal muscle cell membranes by inhibiting AKT/GSK3β phosphorylation].

Authors:  Tianmei Li; Li Liu; Xiaobin Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

3.  Collagen 18 and agrin are secreted by neural crest cells to remodel their microenvironment and regulate their migration during enteric nervous system development.

Authors:  Nandor Nagy; Csilla Barad; Ryo Hotta; Sukhada Bhave; Emily Arciero; David Dora; Allan M Goldstein
Journal:  Development       Date:  2018-05-08       Impact factor: 6.868

4.  Pathogenic effects of agrin V1727F mutation are isoform specific and decrease its expression and affinity for HSPGs and LRP4.

Authors:  John B Rudell; Ricardo A Maselli; Vladimir Yarov-Yarovoy; Michael J Ferns
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

Review 5.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

Review 6.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

Review 7.  Receptor tyrosine kinase activation: From the ligand perspective.

Authors:  Raphael Trenker; Natalia Jura
Journal:  Curr Opin Cell Biol       Date:  2020-02-27       Impact factor: 8.382

8.  Modification of Neuromuscular Junction Protein Expression by Exercise and Doxorubicin.

Authors:  Andres Mor Huertas; Aaron B Morton; J Matthew Hinkey; Noriko Ichinoseki-Sekine; Ashley J Smuder
Journal:  Med Sci Sports Exerc       Date:  2020-07

9.  Osteocytes and mechanical loading: The Wnt connection.

Authors:  Whitney A Bullock; Frederick M Pavalko; Alexander G Robling
Journal:  Orthod Craniofac Res       Date:  2019-05       Impact factor: 2.563

10.  Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity.

Authors:  Joshua R Huot; Fabrizio Pin; Andrea Bonetto
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.